Letter by Putot et al Regarding Article, "Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction"

Circulation. 2021 Feb 23;143(8):e250-e251. doi: 10.1161/CIRCULATIONAHA.120.051103. Epub 2021 Feb 22.

Authors

Alain Putot^{1

2}, Yves Cottin^{1

3}, Marianne Zeller¹

Affiliations

¹ Physiopathologie et Epidémiologie Cérébro-Cardiovasculaires, Université de Bourgogne Franche Comté, Dijon, France (A.P., Y.C., M.Z.).
² Geriatrics Internal Medicine Department (A.P.), University Hospital of Dijon Bourgogne, France.
³ Cardiology Department (Y.C.), University Hospital of Dijon Bourgogne, France.

PMID: 33617310
DOI: 10.1161/CIRCULATIONAHA.120.051103

No abstract available

Publication types

Letter
Comment

MeSH terms

Anterior Wall Myocardial Infarction*
Biomarkers
Humans
Prognosis
ST Elevation Myocardial Infarction*

Substances

Biomarkers